Medicine recalls, shortages and safety updates in the UK — October 2025

MHRA medicines recalls and defect notifications with batch numbers, Serious Shortage Protocols, new approvals and Drug Safety Update — updated daily, automatically. Last updated: 2 Oct 2026 08:50.

All Recalls and defects2 Serious shortages (SSP)2 New approvals1 Drug Safety Update

Sources: we track changes based on information published by the MHRA — medicines recalls and defect notifications, Drug Safety Update and approval announcements — and the Serious Shortage Protocols published by the NHS Business Services Authority. The UK is outside the EU, so European Commission decisions are not listed here.

1 Oct 2025Wednesday 1 October 2025

open day ◀ ▶ 1 event

Medicines recall Levetiracetam Neuraxpharm 250mg granules for oral solution in sachet

Class 4 defect notification · DMRC- 40741691 · PL: 49718/0073 · Neuraxpharm UK Limited · levetiracetam

Batches: 2153678 (09/2027), 2184895 (02/2028), 2184908 (02/2028), 2194807 (04/2028), 2185161 (02/2028), 2194917 (04/2028), 231350 (01/2027), 2145725 (05/2027), 2154064 (10/2027), 2204270 (04/2028), 231175 (01/2027), 231591 (02/2027), 2248690 (06/2029)

What this means, batches, details

Loading…

details and permanent link MHRA alert on GOV.UK ↗ MHRA — Medicines and Healthcare products Regulatory Agency

In total 1 event this month.

Key

class 1 recall (risk to life)

class 2–3 recall, serious shortage, safety update

class 4 defect notification, new approval

A batch recall does not mean the medicine is withdrawn: it remains licensed, only the listed batches are affected.

Sources

MHRA alerts — medicines recalls and defect notifications since January 2024.
Drug Safety Update.
Serious Shortage Protocols (NHSBSA).